A lack of cancer progression could be used as a surrogate for overall survival in newly metastatic prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology.
An experimental drug designed to block blood-clotting proteins may slightly lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
Jeffrey Gordon, MD, a distinguished university professor at Washington University in St. Louis, who is often referred to as the “father of microbiome research,” is the recipient of the 2024 Mechthild Esser Nemmers Prize in Medical Science at Northwestern University.
Northwestern Medicine scientists have identified how a subset of neurons enable the eyes to perceive motion, according to a study published in Nature Communications, a discovery that reveals previously hidden complexities of how vision functions in mammals.
Several recent studies from Feinberg investigators and colleagues have shed light on complex neurological processes and provided new insights and technological developments for neural prostheses.
Some strains of an antibiotic-resistant bacteria may not turn out to be as aggressive as previously thought, according to a Northwestern Medicine study recently published in Nature Communications.
Decreased activity of a specific signaling pathway in the brain vessels of aging mice and humans was linked to a decline in vascular function and subsequent neurodegeneration, according to a recent Northwestern Medicine study published in the Journal of Clinical Investigation.
Eli Zimmerman, MD, has been named associate dean for student affairs at Feinberg, effective January 1, 2024.
Northwestern Medicine scientists have developed a deep learning algorithm accelerating research around diseases and disorders that occur when the process of DNA transcription goes awry.